172 related articles for article (PubMed ID: 30305606)
81. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
[TBL] [Abstract][Full Text] [Related]
82. Low G9a expression is a tumor progression factor of colorectal cancer via IL-8 promotion.
Ichikawa Y; Takahashi H; Chinen Y; Arita A; Sekido Y; Hata T; Ogino T; Miyoshi N; Uemura M; Yamamoto H; Mizushima T; Doki Y; Eguchi H
Carcinogenesis; 2022 Sep; 43(8):797-807. PubMed ID: 35640269
[TBL] [Abstract][Full Text] [Related]
83. Activation of RNA polymerase I transcription by cockayne syndrome group B protein and histone methyltransferase G9a.
Yuan X; Feng W; Imhof A; Grummt I; Zhou Y
Mol Cell; 2007 Aug; 27(4):585-95. PubMed ID: 17707230
[TBL] [Abstract][Full Text] [Related]
84. Translational profiling in childhood acute lymphoblastic leukemia: no evidence for glucocorticoid regulation of mRNA translation.
Aneichyk T; Bindreither D; Mantinger C; Grazio D; Goetsch K; Kofler R; Rainer J
BMC Genomics; 2013 Dec; 14(1):844. PubMed ID: 24289529
[TBL] [Abstract][Full Text] [Related]
85. Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis.
Kato S; Weng QY; Insco ML; Chen KY; Muralidhar S; Pozniak J; Diaz JMS; Drier Y; Nguyen N; Lo JA; van Rooijen E; Kemeny LV; Zhan Y; Feng Y; Silkworth W; Powell CT; Liau BB; Xiong Y; Jin J; Newton-Bishop J; Zon LI; Bernstein BE; Fisher DE
Cancer Discov; 2020 Jul; 10(7):980-997. PubMed ID: 32269030
[TBL] [Abstract][Full Text] [Related]
86. Expression and prognostic significance of chromatin modulators EHMT2/G9a and KDM2b in acute myeloid leukemia.
Gouda MBY; Zidane MA; Abdelhady AS; Hassan NM
J Cell Biochem; 2022 Aug; 123(8):1340-1355. PubMed ID: 35696556
[TBL] [Abstract][Full Text] [Related]
87. Discovery of the First-in-class G9a/GLP PROTAC Degrader.
Velez J; Han Y; Yim H; Yang P; Deng Z; Park KS; Kabir M; Kaniskan HÜ; Xiong Y; Jin J
bioRxiv; 2024 Feb; ():. PubMed ID: 38464025
[TBL] [Abstract][Full Text] [Related]
88. Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
Tamai M; Kasai S; Akahane K; Thu TN; Kagami K; Komatsu C; Abe M; Watanabe A; Goi K; Miyake K; Inaba T; Takita J; Goto H; Minegishi M; Iwamoto S; Sugita K; Inukai T
J Steroid Biochem Mol Biol; 2022 Apr; 218():106068. PubMed ID: 35124168
[TBL] [Abstract][Full Text] [Related]
89. Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia.
Bergeron BP; Diedrich JD; Zhang Y; Barnett KR; Dong Q; Ferguson DC; Autry RJ; Yang W; Hansen BS; Smith C; Crews KR; Fan Y; Pui CH; Pruett-Miller SM; Relling MV; Yang JJ; Li C; Evans WE; Savic D
Leukemia; 2022 Oct; 36(10):2374-2383. PubMed ID: 36028659
[TBL] [Abstract][Full Text] [Related]
90. Histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D.
Weiss T; Hergeth S; Zeissler U; Izzo A; Tropberger P; Zee BM; Dundr M; Garcia BA; Daujat S; Schneider R
Epigenetics Chromatin; 2010 Mar; 3(1):7. PubMed ID: 20334638
[TBL] [Abstract][Full Text] [Related]
91. Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia.
Bergeron BP; Barnett KR; Bhattarai KR; Mobley RJ; Hansen BS; Brown A; Kodali K; High AA; Jeha S; Pui CH; Peng J; Pruett-Miller SM; Savic D
bioRxiv; 2023 May; ():. PubMed ID: 36711662
[TBL] [Abstract][Full Text] [Related]
92. Molecular and functional anticancer effects of GLP/G9a inhibition by UNC0646 in MeWo melanoma cells.
Filiú-Braga LDC; Silva-Carvalho AÉ; Sousa MRR; Carvalho JL; Saldanha-Araujo F
Heliyon; 2024 Mar; 10(5):e27085. PubMed ID: 38434406
[TBL] [Abstract][Full Text] [Related]
93. PI3Kδ Inhibition Potentiates Glucocorticoids in B-lymphoblastic Leukemia by Decreasing Receptor Phosphorylation and Enhancing Gene Regulation.
Zimmerman JAO; Fang M; Pufall MA
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201570
[TBL] [Abstract][Full Text] [Related]
94. Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies.
Scheijen B
Cancer Drug Resist; 2019; 2(3):647-664. PubMed ID: 35582582
[TBL] [Abstract][Full Text] [Related]
95. G9a/GLP catalyzes H3K14me1 and H3K14me2 in vivo and in vitro.
Zhu Q; Chen J; Lu X; Wen H; Zhu WG
Sci China Life Sci; 2022 May; 65(5):1043-1045. PubMed ID: 35192124
[No Abstract] [Full Text] [Related]
96. Modeling the Mechanism of GR/c-Jun/Erg Crosstalk in Apoptosis of Acute Lymphoblastic Leukemia.
Chen DW; Krstic-Demonacos M; Schwartz JM
Front Physiol; 2012; 3():410. PubMed ID: 23181019
[TBL] [Abstract][Full Text] [Related]
97. Steroid resistance in leukemia.
Shah DS; Kumar R
World J Exp Med; 2013 May; 3(2):21-5. PubMed ID: 24520542
[TBL] [Abstract][Full Text] [Related]
98. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia.
Poulard C; Kim HN; Fang M; Kruth K; Gagnieux C; Gerke DS; Bhojwani D; Kim YM; Kampmann M; Stallcup MR; Pufall MA
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3052-3061. PubMed ID: 30733284
[TBL] [Abstract][Full Text] [Related]
99. PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.
Noureddine LM; Ablain J; Surmieliova-Garnès A; Jacquemetton J; Pham TH; Marangoni E; Schnitzler A; Bieche I; Badran B; Trédan O; Hussein N; Le Romancer M; Poulard C
Life Sci Alliance; 2023 Oct; 6(10):. PubMed ID: 37536978
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
